Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFRL858R/T790M/C797S

被引：50

作者：

Li, Qiannan ^{[1
]}

Zhang, Tao ^{[2
]}

Li, Shiliang ^{[1
]}

Tong, Linjiang ^{[2
]}

Li, Junyu ^{[1
]}

Su, Zhicheng ^{[1
]}

Feng, Fang ^{[2
]}

Sun, Deheng ^{[1
]}

Tong, Yi ^{[1
]}

Wang, Xia ^{[1
]}

Zhao, Zhenjiang ^{[1
]}

Zhu, Lili ^{[1
]}

Ding, Jian ^{[2
]}

Li, Honglin ^{[1
]}

Xie, Hua ^{[2
]}

Xu, Yufang ^{[1
]}

机构：

[1] East China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 06期

基金：

中国国家自然科学基金;

关键词：

EGFR; mutant; inhibitor; C797S; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; MUTATIONS; GEFITINIB; AZD9291;

D O I：

10.1021/acsmedchemlett.8b00564

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In this paper, we describe the discovery and optimization of a series of noncovalent reversible epidermal growth factor receptor inhibitors of EGFR(L858R/T790M/C797S). One of the most promising compounds, 25g, inhibited the enzymatic activity of EGFR(L8S8R/T790M/C797S) with an IC50 value of 2.2 nM. Cell proliferation assays showed that 25g effectively and selectively inhibited the growth of EGFR(L858R/T790M/C797S)-dependent cells. This series of compounds, which occupy both the ATP binding site and the allosteric site of the EGFR kinase, may serve as a basis for the development of fourth-generation EGFR inhibitors for L858R/T790M/C797S mutants.

引用

页码：869 / 873

页数：9

共 50 条

[41] Binding mechanism of kinase inhibitors to EGFR and T790M, L858R and L858R/T790M mutants through structural and energetic analysis
Bello, Martiniano
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 118 : 1948 - 1962
[42] Generation of a triple-mutation (T790M/C797S/L858R) NSCLC cell line for relevant drug discovery and development
Ma, Huiying
Li, Peixue
Zhang, Peiran
Sun, Fuyun
Lin, Qing
CANCER RESEARCH, 2020, 80 (16)
[43] Antitumor activity and mechanisms of dual EGFR/DNA-targeting strategy for the treatment of lung cancer with EGFRL858R/T790M mutation
Dai, Lumei
Qin, Feng
Xie, Yuying
Zhang, Bin
Zhang, Zhijie
Liang, Sijia
Chen, Fujia
Huang, Xiaochao
Wang, Hengshan
BIOORGANIC CHEMISTRY, 2023, 135
[44] A new mouse model for epithelial ear neoplasms based upon expression of mutant EGFRL858R/T790M
Kawabata, Shigeru
Hollander, M. Christine
Munasinghe, Jeeva P.
Mercado, Jose
Brinster, Lauren R.
Butman, John A.
Lonser, Russell R.
Regales, Lucia
Pao, William
Janne, Pasi A.
Wong, Kwok-Kin
Dennis, Phillip A.
CANCER RESEARCH, 2011, 71
[45] Discovery of novel 4-arylamino-quinazoline derivatives as EGFRL858R/T790M inhibitors with the potential to inhibit the non-small cell lung cancers
Gan, Wenhui
Wang, Caolin
Pan, Qingshan
Li, Yuzhen
Guo, Yuping
Fan, Dang
Peng, Yuting
Rao, Zixuan
Xu, Shan
Zheng, Pengwu
Zhu, Wufu
BIOORGANIC CHEMISTRY, 2022, 127
[46] Design, synthesis and biological evaluation of novel 2,4-diaryl pyrimidine derivatives as selective EGFRL858R/T790M inhibitors
Li, Jianheng
An, Baijiao
Song, Xianheng
Zhang, Qianzhong
Chen, Chun
Wei, Shuxian
Fan, Runzhu
Li, Xingshu
Zou, Yong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
[47] Molecular Docking, Pharmacokinetic and Molecular Simulation Analysis of Novel Mono-Carbonyl Curcumin Analogs as L858R/T790M/C797S Mutant EGFR Inhibitors
Bhandari, Shashikant V.
Kuthe, Pranali V.
Patil, Shital M.
Nagras, Om G.
Sarkate, Aniket P.
Chaudhari, Somdatta Y.
Surve, Sandip V.
CHEMISTRY & BIODIVERSITY, 2023, 20 (11)
[48] Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045
Zhao, Peng
Yao, Ming-Yu
Zhu, Su-Jie
Chen, Ji-Yun
Yun, Cai-Hong
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 502 (03) : 332 - 337
[49] Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFRL858R/T790M kinase inhibitors
Ding, Shi
Dong, Xiaoyong
Gao, Ziye
Zheng, Xiangshan
Ji, Jingchao
Zhang, Mingjuan
Liu, Fang
Wu, Shuang
Li, Min
Song, Wenshan
Shen, Jiwei
Duan, Wenwen
Liu, Ju
Chen, Ye
BIOORGANIC CHEMISTRY, 2022, 118
[50] Design, Synthesis and Biological Evaluation of the Quinazoline Derivatives as L858R/T790M/C797S Triple Mutant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Zhang, Mingguang
Wang, Yunyun
Wang, Jia
Liu, Zhaogang
Shi, Jingmiao
Li, Mingxin
Zhu, Yongqiang
Wang, Shifa
CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (10) : 971 - 980

← 1 2 3 4 5 →